Proposed Rules. Advance notice of proposed rulemaking; extension of comment period; correction
/register/2003/10/06/03-25044·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Agency: Food and Drug Administration, HHS
Action: Advance notice of proposed rulemaking; extension of comment period; correction
Citation: FR Doc. 03-25044 · Docket No. 81N-033P · 21 CFR 356
Summary
The Food and Drug Administration (FDA) is correcting a document that appeared in the Federal Register of August 25, 2003 (68 FR 50991). The document announced that FDA extended to November 25, 2003, the comment period for an advance notice of proposed rulemaking (ANPR) for over-the-counter antigingivitis/antiplaque drug products. The ANPR was published in the Federal Register of May 29, 2003 (68 FR 32232). The document published with an inadvertent error. This document corrects that error.
Dates
Submit written or electronic comments by November 25, 2003. Submit reply comments by February 23, 2004.
Supplementary Information
In FR Doc. 03-21669, appearing on page 50992 in the Federal Register of August 25, 2003, the following correction is made: 1. On page 50992, in the second column, under IV. Comments , in the sixth line, “two” is corrected to read “three”. Dated: September 25, 2003. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 03-25044 Filed 10-3-03; 8:45 am]
Connections1 off-index
- 21 CFR 356